Surgical Decision-Making and Treatment Response in Invasive Lobular Carcinoma Treated with Primary Surgery or Neoadjuvant Therapy
This retrospective study of 104 invasive lobular carcinoma cases reveals that neoadjuvant systemic therapy yields limited pathological response and fails to significantly increase breast-conserving treatment rates compared to primary surgery, highlighting the challenges of managing ILC's distinct biological features.